Skip to main content
SpringerLink
Log in

Phase II study of high-dose ifosfamide in hepatocellular carcinoma

  • Short Communication
  • High-Dose Ifosfamide, Hepatocellular Carcinoma, Chemotherapy
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

Summary

A phase II study of high-dose ifosfamide in hepatocellular carcinoma was conducted among 17 Chinese patients. The dose of ifosfamide used was 2.5 g/m2 daily given as a continuous infusion for 5 days. In all, 15 patients were evaluable for tumour response. There was no complete or partial responder. The treatment was well tolerated. The most frequent toxicity was alopecia, which occurred in 11 patients, and 5 patients developed mild haematological toxicity. There was no evidence of liver or bladder toxicity. Overall, 14 patients were evaluable for survival. The median survival was 92 days (range, 30–568 days). We conclude that high-dose ifosfamide is well tolerated but ineffective in hepatocellular carcinoma in Chinese patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Brade WP, Herdrich K, Varini M (1985) Ifosfamide pharmacology, safety and therapeutic potential. Cancer Treat Rev 12:1–47

    Google Scholar 

  2. Falkson G, Macintyre J, Moertel C, et al. (1984) Primary liver cancer: an Eastern Cooperative Oncology Group trial. Cancer 54:970–977

    Google Scholar 

  3. Institute of Radiology and Oncology (1986) Cancer incidence in Hong Kong. Cancer Registry, Medical and Health Department, Hong Kong

    Google Scholar 

  4. Liver Cancer Study Group of Japan (1984) Primary liver cancer in Japan. Cancer 54:1747–1755

    Google Scholar 

  5. Okamoto E, Yamanaka N, Toyosaka A, Tanaka N, Yabuki K (1987) Current status of hepatic resection in the treatment of hepatocellular carcinoma. In: Okuda K, Ishak KG (eds) Neoplasms of the liver. Springer, Berlin Heidelberg New York Tokyo, p 356

    Google Scholar 

  6. Shiu W, Mok SD, Leung N, Li M, Zacharia A, Li A, Martin C (1987) Phase II study of high dose etoposide in hepatocellular carcinoma. Jpn J Clin Oncol 17:113–115

    Google Scholar 

  7. Shiu W, Leung N, Li M, Leung WT, Li AKC (1988) The efficacy of high dose 4′-epidoxorubicin in hepatocellular carcinoma. Jpn J Clin Oncol 18:235–237

    Google Scholar 

  8. Thongprasert S, Klunklin K, Phornphutkul K, et al (1988) Phase II study of ifosfamide in hepatoma. Eur J Cancer Clin Oncol 24: 1793–1796

    Google Scholar 

  9. World Health Organization (1979) Handbook for reporting results of cancer treatment, World Health Organization, Geneva

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Oncology, Prince of Wales Hospital, Chinese University of Hong Kong, Shatin, Hong Kong

    J. Lin, W. Shiu, W. T. Leung & M. Tao

  2. Department of Medicine, Prince of Wales Hospital, Chinese University of Hong Kong, Shatin, Hong Kong

    N. Leung

  3. Department of Surgery, Prince of Wales Hospital, Chinese University of Hong Kong, Shatin, Hong Kong

    W. Y. Lau & A. K. C. Li

Authors
  1. J. Lin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. W. Shiu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. W. T. Leung
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. Tao
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. N. Leung
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. W. Y. Lau
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. A. K. C. Li
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lin, J., Shiu, W., Leung, W.T. et al. Phase II study of high-dose ifosfamide in hepatocellular carcinoma. Cancer Chemother. Pharmacol. 31, 338–339 (1993). https://doi.org/10.1007/BF00685682

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00685682

Keywords

Search

Navigation